Antifungal Treatment Duration in Hematology Patients With Invasive Mold Infections: A Real-life Update.

Vera PortilloSilvio RagozzinoElisavet StavropoulouCeline El-KhouryPierre-Yves BochudFrederic Lamoth Nina Khanna Dionysios Neofytos

Published in: Open forum infectious diseases (2024)

AFT in patients with acute myelogenous leukemia and IMI is longer than that recommended by guidelines and is frequently associated with treatment adjustments due to variable reasons. More data and better guidance are required to optimize AFT duration and secondary prophylaxis administration according to immunosuppression.

Keyphrases

acute myeloid leukemia
electronic health record
combination therapy
replacement therapy
smoking cessation